The Health Data Lifecycle
The health data lifecycle covers how information is collected, used, stored, shared, retained and eventually disposed of.
#Begin with how the data was generated
Weng describes a research-reuse life cycle that begins with data generation. Clinical documentation reflects care processes, the people recording it and the systems they use. Decisions made at this stage can affect what later researchers see.
Read who collected the information, for what purpose and under what definitions. Understanding a dataset starts before its analysis. A later research question may require information that the original collection was never designed to capture.
#Follow transformations, not only the final table
Data may be extracted, transformed and combined before reuse. Weng describes how these steps can introduce errors or lose information and context. Provenance means keeping track of where data came from and what happened to it.
Read how records were selected, converted and linked, and whether limitations were documented. A common format helps exchange information but is not proof that the source meaning was preserved. A traceable processing history makes it easier to investigate unexpected results.
#Storage and sharing are part of governance
The OECD includes collection, storage, editing, transfer, linkage, analysis and erasure within personal-health-data processing. Its recommendation calls for accountability, risk management and technical, physical and organizational safeguards, including secure transfer arrangements.
A life-cycle description should therefore address responsibilities and access, not only a diagram of data moving between systems. Read what purposes and protections apply. These are governance principles, not a universal retention period or a legal authorization to share patient information.
#Reuse should create feedback, not hide problems
Weng includes post-reuse quality reporting and feedback in the life cycle. Problems discovered during research can be difficult to trace if the researchers, data curators and original recorders do not communicate. Documenting a limitation helps future users understand what the data can support.
The OECD likewise recommends monitoring uses, benefits, negative consequences and safeguards. A lifecycle is not finished simply because an analysis ran successfully. This page describes reading questions, not an operating Mynd data pipeline, patient-record store or disposal policy.
Evidence: Weng: clinical data quality across its life cycle / OECD: recommendation on health data governance
Source note
The sections above were checked against the linked sources. No clinical review has been performed. This is general research education, not a clinical guideline.